Could a daily pill replace needles for hemophilia a?
NCT ID NCT07220564
First seen Jun 27, 2026 · Last updated Aug 11, 2026 · Updated 2 times
Summary
This study tests an experimental oral medicine called Inno8 in 30 adults with hemophilia A. The goal is to see if it is safe and how the body processes it. Participants will take multiple doses over about 11 weeks. If successful, Inno8 could offer a more convenient way to control bleeding without regular injections.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
AKH - Klin. Abt. f. Haematologie u. Haemostaseologie
RECRUITINGVienna, 1090, Austria
-
AOU Careggi Firenze
RECRUITINGFlorence, 50134, Italy
-
Azienda Ospedaliera Universitaria Federico II di Napoli
RECRUITINGNaples, 80131, Italy
-
Cliniques universitaires Saint-Luc
NOT_YET_RECRUITINGBrussels, 1200, Belgium
-
HCL - HOPITAL LOUIS PRADEL - Unité d'hémostase Clinique
RECRUITINGBron, 69500, France
-
Hospital Clinico Universitario de Salamanca
RECRUITINGSalamanca, 37007, Spain
-
Hospital La Fe_Hemostasia y Trombosis
RECRUITINGValencia, 46026, Spain
-
Hospital Regional Universitario de Málaga
RECRUITINGMálaga, 29010, Spain
-
Hospital Universitario La Paz
RECRUITINGMadrid, 28046, Spain
-
Hospital Vall d'Hebron
RECRUITINGBarcelona, 08035, Spain
-
Indiana Hemophilia-Thromb Ctr
RECRUITINGIndianapolis, Indiana, 46260, United States
-
Instytut Hematologii i Transfuzjologii
RECRUITINGWarsaw, 02-776, Poland
-
KS Solna - Koagulationsmottagningen
RECRUITINGSolna, 171 64, Sweden
-
Medizinische Hochschule Hannover - Hämatologie, Hämostaseologie, Onkologie
RECRUITINGHanover, 30625, Germany
-
Penn State MS Hershey Med Ctr
RECRUITINGHershey, Pennsylvania, 17033-2360, United States
-
Queen Elizabeth Hospital, Birmingham - Haemophilia
RECRUITINGBirmingham, B15 2TH, United Kingdom
-
Royal Free Hospital - Haemophilia
RECRUITINGLondon, NW3 2QG, United Kingdom
-
Royal Hallamshire Hospital
RECRUITINGSheffield, S10 2JF, United Kingdom
-
Samodzielny Publiczny Szpital Kliniczny im. Andrzeja Mielęckiego Slaskiego Uniwersytetu Medycznego w Katowicach
NOT_YET_RECRUITINGKatowice, 40-032, Poland
-
Skåne US - Koagulationsmottagning
RECRUITINGMalmö, 214 28, Sweden
-
St Christopher Hosp for Child
RECRUITINGPhiladelphia, Pennsylvania, 19134, United States
-
UC Denver Hemoph & Thrombo Ctr
RECRUITINGAurora, Colorado, 80045, United States
-
ULS De Santo António, E.P.E. _H.Santo António_ Imunohemoterapia
NOT_YET_RECRUITINGPorto, 4050-342, Portugal
-
ULS São João, E.P.E._H.São João_Imunohemoterapia
RECRUITINGPorto, 4200-319, Portugal
-
University of Iowa_Iowa City
RECRUITINGIowa City, Iowa, 52242, United States
-
Universitätsklinik für Innere Medizin V
RECRUITINGInnsbruck, 6020, Austria
-
Universitätsklinikum Bonn - Institut für Experimentelle Hämatologie
NOT_YET_RECRUITINGBonn, 53127, Germany
-
Uniwersytecki Szpital Kliniczny W Poznaniu
NOT_YET_RECRUITINGPoznan, 60-569, Poland
-
Uniwersytecki Szpital Kliniczny nr 1 Klinika Hematoonkologii i Transplantacji Szpiku
NOT_YET_RECRUITINGLublin, 20-081, Poland
-
Uniwersytecki Szpital Kliniczny w Bialymstoku
RECRUITINGBialystok, 15-276, Poland
-
Uniwersyteckie Centrum Kliniczne
RECRUITINGGdansk, 80-214, Poland
-
Vivantes Netzwerk für Gesundheit GmbH - Vivantes Klinikum im Friedrichshain
RECRUITINGBerlin, 10249, Germany
-
Zentrum für Labormedizin
NOT_YET_RECRUITINGSankt Gallen, 9008, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an ultra-long-acting factor VIII simplify surgery for hemophilia a patients?
- Patient voices take center stage in haemophilia a treatment decisions
- Japanese study tracks Esperoct's Real-World safety over two years
- Japanese hemophilia patients monitored on alhemo in new safety study
- New hope for haemophilia a patients: immune tolerance induction may eliminate clotting factor blockers
- New hope for kids with hemophilia: can SCT800 stop bleeds before they start?